Thirty-seven patients were randomized to arm C ( weekly cisplatin 40mg/m ( 2 ) ) and 37 patients were randomized to arm CG ( weekly cisplatin 40mg/m ( 2 ) and gemcitabine 125mg/m ( 2 ) ) , for six cycles .